Multiple Sclerosis Archives - Express Pharma

Climate change to drive growth in multiple sclerosis market: GlobalData

IIT Kanpur study unveil insights into working mechanism of cholesterol lowering drugs

Multiple sclerosis market to generate sales of $29.8 bn by 2030: GlobalData

US FDA nod for Ocrevus (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive MS

Zydus Cadila gets US FDA approval for fingolimod capsules and verapamil hydrochloride injection

US FDA approves Zydus Cadila’s dimethyl fumarate DR capsules

Cipla gets US FDA approval for dimethyl fumarate DR capsules

US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment

Mylan announces launch of generic version of Biogen’s Tecfidera

FDA approves first generics of Gilenya